EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/ CBFB::MYH11

Juehua Gao, Lucas Santana-Santos, Lucy Fu iD, Emily Alvey, Qing Chen iD, Kristy Wolniak iD, Zongjun Xia, Barina Aqil, Amir Behdad, Peng Ji iD, Madina Sukhanova iD, Yasmin Abaza und 3 weitere

European Journal of Haematology · 2024

DOI: 10.1111/ejh.14192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Juehua Gao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, Chromosome Inversion, Chromosomes, Human, Pair 16. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study assesses the clinical significance of additional cytogenetic abnormalities (ACAs) and/or the deletion of 3′ CBFB (3′ CBFB del ) resulting in unbalanced CBFB::MYH11 fusion in acute myeloid leukemia (AML) with inv (16)/t(16;16)/ CBFB::MYH11 .

Methods

We retrospectively evaluated the clinicopathologic features of 47 adult de novo AML with inv (16)/t(16;16)/ CBFB::MYH11 fusion. There were 44 balanced and 3 unbalanced CBFB::MYH11 fusions. Given the low frequency of unbalanced cases, the latter group was combined with 19 published cases ( N = 22) for statistic and meta‐analysis.

Results

Both balanced and unbalanced cases were characterized by frequent ACAs (56.5% and 72.7%, respectively), with +8, +22, and del(7q) as the most frequent abnormalities. The unbalanced group tends to be younger individuals ( p = .04) and is associated with a lower remission rate ( p = .02), although the median overall survival (OS) was not statistically different ( p = .2868). In the balanced group, “ACA” subgroup had higher mortality ( p = .013) and shorter OS ( p = .011), and patients with relapsed disease had a significantly shorter OS ( p = .0011). Cox multivariate regression analysis confirmed that ACAs and history of disease relapse are independent risk factors, irrespective of disease relapse status. In the combined cohort, cases with ACAs had shorter OS than those with “Sole” abnormality ( p = .0109).

Conclusions

ACAs are independent high‐risk factors in adult AML with inv (16)/t(16;16)/ CBFB::MYH11 fusion and should be integrated for risk stratification in this disease. Larger studies are needed to assess the clinical significance of the unbalanced CBFB::MYH11 fusion resulting from the 3′ CBFB del .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteOncogene Proteins, FusionChromosome InversionChromosomes, Human, Pair 16Chromosome AberrationsHumansAdultFemaleMaleMiddle AgedAgedPrognosisRetrospective StudiesYoung AdultCore Binding Factor beta SubunitAdolescentAged, 80 and overTranslocation, GeneticMyosin Heavy Chains

Stichwörter der Autor:innen

AMLCBFB::MYH11 fusionacute myeloid leukemiaadditional chromosomal abnormalities (ACAs)cytogenetic heterogeneityinv (16)/t(16;16)

Substanzen

Oncogene Proteins, FusionCore Binding Factor beta SubunitCBFbeta-MYH11 fusion proteinCBFB protein, humanMYH11 protein, humanMyosin Heavy Chains

Autor:innen und Institutionen

  • Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Internal Medicine, Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Lucy Fu, Qing Chen, Kristy Wolniak, Peng Ji, Madina Sukhanova, Jessica K Altman, Xinyan Lu

Zitieren

APA

Gao, J., Santana-Santos, L., Fu, L., Alvey, E., Chen, Q., Wolniak, K., Xia, Z., Aqil, B., Behdad, A., Ji, P., Sukhanova, M., Abaza, Y., Altman, J. K., Chen, Y. H., & Lu, X. (2024). Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/ CBFB::MYH11. European Journal of Haematology. https://doi.org/10.1111/ejh.14192

Vancouver

Gao J, Santana-Santos L, Fu L, Alvey E, Chen Q, Wolniak K, et al. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/ CBFB::MYH11. European Journal of Haematology. 2024. doi:10.1111/ejh.14192

BibTeX
@article{Gao2024,
  author = {Gao, Juehua and Santana-Santos, Lucas and Fu, Lucy and Alvey, Emily and Chen, Qing and Wolniak, Kristy and Xia, Zongjun and Aqil, Barina and Behdad, Amir and Ji, Peng and Sukhanova, Madina and Abaza, Yasmin and Altman, Jessica K and Chen, Yi-Hua and Lu, Xinyan},
  title = {Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/ CBFB::MYH11},
  journal = {European Journal of Haematology},
  year = {2024},
  doi = {10.1111/ejh.14192}
}
Kostenlos starten →